Jump to content

Eden Research


Guest Mutley

Recommended Posts

Has anyone done any research or analysis on Eden Research an AIM-listed company  that develops and supplies breakthrough bio-pesticide products? Its markets centre around crop protection, animal health and consumer products. It has spent several years building its IP portfolio and has been successful in achieving patent protection and product approvals in Europe and elsewhere. It has now started to commercialise its offering with several partners who are big players in the agricultural and crop protection markets.

I think it has really exciting prospects in its targeted markets in the medium to long term but it is difficult to find independent analysis for what is a small company having little following.

Interested to hear from anyone else who is invested in the company or has any particular insight.

Link to comment

Many thanks for taking the time to respond and your insight on AIM shares. 

I have always appreciated the liquidity issues and unfortunately that is a risk that has been a problem ever since AIM was established. Problem is institutional investors very rarely invest to any significant extent until a trend does emerge and therein lies the problem for the small private investor who would like to invest in early stage . Once institutional investors do become interested the price rises before private investors get a chance and they end buying at a substantially higher price. this pushes the price further , institutions take some profit, depress the price, private investors panic further depressing the price and institutions buy back in. All a vicious circle. Welcome to AIM!!??

I am in already in (modestly) so will see where it goes - fingers and everything else crossed. Not a good investment stategy!!!!!!!!

Link to comment

Very wise words and I agree. Stop loss already in place and will certainly not be increasing my position until I see some strong reasons to do so.

Once again many thanks.

Link to comment

Archived

This topic is now archived and is closed to further replies.

  • image.png

  • Posts

    • As of now, Cardano (ADA) is priced at $0.3357. Despite recent challenges, experts believe the cryptocurrency has strong potential. According to their ADA price prediction, it could rise to $1 by the end of 2024 and reach an astonishing $10.32 by 2030. Recent Trading Performance Cardano has been trading lower than its earlier highs in 2024, with a recent closing price of $0.33. Fortunately, it has strong support at $0.20, which has helped prevent further declines. In the last few weeks, ADA saw a 5% increase since September. However, it experienced a 2.4% drop recently, partly due to large investors selling their holdings amid rising geopolitical tensions. Technical Analysis Technical indicators show a weakening bullish momentum for Cardano. Resistance has formed around the $0.40 mark, leading to a potential short-term pullback. Despite this bearish sentiment, a bullish breakout from a falling channel pattern has seen ADA rise 4.65% in the last 24 hours, breaking through the $0.35 resistance level. Future Predictions Looking ahead, analysts believe Cardano’s price could steadily rise to $0.81 by 2025. If this bullish trend continues, ADA might challenge the $0.489 Fibonacci level. While market volatility remains, this current consolidation phase could set the stage for significant gains in the future. In summary, despite recent fluctuations, the outlook for Cardano (ADA) remains positive. With strong support and potential for growth, investors will be watching closely to see how this cryptocurrency develops in the coming months.
    • SUN PHARMACEUTICALS – SUNPHARMA (1D Chart) Elliott Wave Technical Analysis Function: Larger Degree Trend Higher (Intermediate Degree orange) Mode: Motive Structure: Impulse Position: Minute Wave ((v)) Navy Details: Minute Wave ((v)) of Minor Wave 3 Grey might be complete around 1950-75 range. Please note that 2000 mark is major resistance. Alternatively Minor Waves 3, 4 and 5 could be complete as marked, and a larger degree corrective wave could resume soon. Invalidation point: 1830 risk tightened Sun Pharmaceuticals Daily Chart Technical Analysis and potential Elliott Wave Counts Sun Pharmaceuticals daily chart is suggesting Minor Wave 3 Grey might be complete around 1975-80 zone or near to completion. If correct, expect a turn lower to unfold Minor Wave 4 towards 1380 at least. Alternatively, Minor Waves 3, 4 and 5 are now complete and the stock is ready for a much deeper correction. The stock bottomed around 790 low in June 2022, terminating Intermediate Wave (4) Orange. The rally since then has potentially sub divided into 3 waves with Minor Wave 3 and Minute Wave ((iii)) extended. Minute Wave ((iv)) of 3 terminated around 1380 on June 0, 2024. Minute Wave ((v)) of 3 has been unfolding against 1380 mark and looks complete just below the 2000 mark. If the above proposed wave counts hold well, we should witness a corrective drop as Minor Wave 4 begins to unfold. We will highlight the alternate count with respect to price action going forward.   SUN PHARMACEUTICALS – SUNPHARMA (4H Chart) Elliott Wave Technical Analysis Function: Larger Degree Trend Higher (Intermediate Degree orange) Mode: Motive Structure: Impulse Position: Minute Wave ((v)) Navy Details: Minute Wave ((v)) of Minor Wave 3 Grey might be complete around 1950-75 range. Please note that 2000 mark is major resistance. Alternatively Minor Waves 3, 4 and 5 could be complete as marked on the daily chart, and a larger degree corrective wave could resume soon. Invalidation point: 1830 risk tightened Sun Pharmaceuticals 4H Chart Technical Analysis and potential Elliott Wave Counts: Sun Pharmaceuticals 4H chart primarily highlights the sub waves since Minute Wave ((iv)) of Minor Wave 3 terminated around 1380 mark. High probability remains that Minor Wave 3 Grey is complete around 1975-80 as bears prepare to drag lower soon. Conclusion: Sun Pharmaceuticals has potentially terminated Minor Wave 3 Grey with Intermediate Wave (5) Orange around 1975-80. Watch out for a corrective drop as Minor Wave 4 should be underway soon. Elliott Wave Analyst: Harsh Japee Source : Tradinglounge.com get trial here!  
    • In my opinion, Ethereum’s price could potentially surpass the $2,580 mark, but several factors need to align. Ethereum has strong fundamentals, especially with its shift to Proof of Stake and growing use cases like DeFi and NFTs. However, market sentiment, overall crypto adoption, and external economic conditions will play a significant role in its price movement. If institutional interest continues and Ethereum maintains its network upgrades efficiently, breaking through $2,580 is realistic, though volatility remains a key factor to consider.
×
×
  • Create New...
us